CAS Medical Systems Inc  

(Public, NASDAQ:CASM)   Watch this stock  
Find more results for CASM
+0.01 (0.58%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.65 - 1.75
52 week 1.01 - 1.98
Open 1.74
Vol / Avg. 15,750.00/65,045.00
Mkt cap 46.24M
P/E     -
Div/yield     -
EPS -0.34
Shares 26.88M
Beta -0.12
Inst. own 49%
Dec 2, 2015
CAS Medical Systems Inc at LD Micro Main Event Conference - 12:30PM EST - Add to calendar
Nov 5, 2015
Q3 2015 CAS Medical Systems Inc Earnings Call
Nov 5, 2015
Q3 2015 CAS Medical Systems Inc Earnings Release
Sep 17, 2015
CAS Medical Systems Inc at Craig-Hallum Alpha Select Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -30.33% -33.18%
Operating margin -26.67% -29.82%
EBITD margin - -22.52%
Return on average assets -34.35% -45.25%
Return on average equity - -
Employees 97 -
CDP Score - -


44 E Industrial Rd
BRANFORD, CT 06405-6507
United States - Map
+1-203-4886056 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


CAS Medical Systems, Inc. is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products that are vital to patient care. The Company also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, stand-alone patient vital signs monitors, and neonatal medical disposables. Its principal products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It provides a series of vital signs monitoring products and services to clinicians, including sales to original equipment manufacturers (OEM) of the Company's non-invasive blood pressure technology, vital signs monitors and accessories and supplies and service, including neonatal intensive care vital signs supplies. It has developed a non-invasive blood pressure measurement technology under the MAXNIBP and MAXIQ brands.

Officers and directors

Thomas M. Patton President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Jeffrey A. Baird Chief Financial Officer, Secretary
Age: 61
Bio & Compensation  - Reuters
Kimberly K. Strusky Executive Vice President - U.S. Sales
Bio & Compensation  - Reuters
Paul B. Benni Chief Scientific Officer
Age: 47
Bio & Compensation  - Reuters
John R. Gamelin Ph.D. Vice President - Research & Development
Age: 49
Bio & Compensation  - Reuters
James E. Thomas Lead Independent Director
Age: 54
Bio & Compensation  - Reuters
Alan W. Milinazzo Director
Age: 55
Bio & Compensation  - Reuters
Paul A. Molloy Director
Age: 53
Bio & Compensation  - Reuters
Gregory P. Rainey Independent Director
Age: 62
Bio & Compensation  - Reuters
Kathleen A. Tune Independent Director
Age: 50
Bio & Compensation  - Reuters